Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain

European Heart Journal

Volumn 19, Issue 1, 1998, Pages 80-84

  Pizzulli, Luciano ^a   Yang, A ^a   Martin, J F ^b   Luderitz B ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary atherosclerosis; Platelets; Unstable angina

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THORAX PAIN; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TURNOVER TIME; UNSTABLE ANGINA PECTORIS;

ADULT; ANGINA PECTORIS; ANGINA, UNSTABLE; ARTERIOSCLEROSIS; BLOOD PLATELETS; CHEST PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT;

EID: 0031912953     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0747     Document Type: Article

References (39)

1. [1] Lewis HD, Dawis JW, Archibald DG et al. Protective effects of aspirin against acute MI and death in men with unstable angina: results of a Veterans Administration Cooperative study. N Engl J Med 1983; 309: 396-403.
2. [2] The RISK Group. Risk of MI and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
3. [3] Theroux P, Ouimet H, McCans J et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988; 319: 1105-11.
4. [4] The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
5. [5] Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32: 443-60.
6. [6] Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after MI. Lancet 1991; 338: 1409-11.
7. [7] Ishibashi T, Burstein SA. Interluekin 3 promotes the differentiation of isolated single megakaryocytes. Blood 1986; 67: 1512-14.
8. [8] Imai T, Koike K, Kubo T et al. Interleukin 6 supports human megakaryocytes proliferation and differentiation in vitro. Blood 1991; 78: 1969-74.
9. [9] Teramura M, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H. Interleukin 11 enhances human megakaryocytopoiesis in vitro. Blood 1992; 79: 327-31.
10. [10] Brown AS, Hong Y, de Beider A et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-7.
11. [11] Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
12. [12] Kristensen SD, Martin JF. Megakaryocytes and atherosclerosis. Clin Sci 1992; 82: 353-5.
13. [13] de Belder A, Radomski A, Hancock V, Brown A, Moncada S, Martin JF. Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 1995; 15: 631-41.
14. [14] Kishk YT, Trowbridge EA, Martin JF. Platelet volume subpopulations in acute MI: an investigation of their homogeneity for smoking, infarct size and site. Clin Sci 1985; 68: 419-25.
15. [15] Ljungberg B, Beving H, Egberg N, Johnsson H, Vesterqvist O. Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors. Thromb Res 1988; 51: 209-17.
16. [16] Martin JF, Shaw T, Heggie J, Penington DG. Measurement of the density of human platelets and its relationship to volume. Br J Haematol 1983; 54: 337-52.
17. [17] Thompson CB, Diaz DD, Quinn PG, Lapins M, Kurtz SR, Valeri CR. The role of anticoagulation in the measurement of platelet volumes. Am J Clin Pathol 1983; 80: 327-32.
18. [18] Tofler GH, Brezinski D, Schafer AI et al. Concurrent morning increase in platelet aggregability and the risk of MI and sudden cardiac death. N Engl J Med 1987; 316: 1514-18.
19. [19] Fitzgerald DJ, Roy L, Castella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-9.
20. [20] Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-17.
21. [21] Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of MI. N Engl J Med 1990; 322: 1549-54.
22. [22] Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell WG. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 1991; 83; 38-44.
23. [23] Eldor A, Avitzour M, Or R, Hanna R, Penchas S. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J 1982; 285: 397-400.
24. [24] Kristensen SD, Milner PC, Martin JF. Bleeding time and platelet volume in acute MI. A 2-year follow-up study. Thromb Haemostas 1988; 59: 353-63.
25. [25] Haver VM, Gear ARL. Functional fractionation of platelets. J Lab Clin Med 1981; 97: 187-204.
26. [26] Thompson CB, Eaton KA, Princiotta SM, Kushkin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982; 50: 509-19.
27. [27] Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med 1981; 101: 205-13.
28. [28] Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983; 53: 503-11.
29. [29] Tschoepe D, Rosen P, Kaufmann L et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 1990; 20: 166-70.
30. [30] Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol 1989; 63: 114E-20E.
31. [31] Falk E. Unstable angina with fatal outcome. Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985; 71: 699-708.
32. [32] Willerson JT, Golino P, Eidt J, Campbell WB, Buja M. Specific platelet mediators and unstable coronary artery lesions: Experimental evidence and potential clinical implications. Circulation 1989; 80: 198-205.
33. [33] Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischaemic death. N Engl J Med 1984; 310: 1137-40.
34. [34] Horie T, Sekiguchi M, Hirosawa K. Coronary thrombosis in pathogenesis of acute MI. Histopathological study of coronary arteries in 108 necropsied cases using serial section. Br Heart J 1978; 40: 153-61.
35. [35] Martin JF. The relationship between megakaryocytes ploidy and platelet volume. Blood Cells 1989; 15: 108-17.
36. [36] Martin JF, Plumb J, Kilbey RS, Kishk YT. Changes in volume and density of platelets in MI. Br Med J 1983; 287: 456-9.
37. [37] Cameron A, Phillips R, Ibbotson RM, Carson PHM. Platelet size in MI. Br Med J 1983; 287: 449-51.
38. [38] Trowbridge EA, Slater DN, Kishk YT et al. Platelet production in MI and sudden cardiac death. Thromb Haemostas 1984; 52: 167-71.
39. [39] Bath PMW, Gladwin AM, Garden N, Martin JF. Megakaryocyte DNA content is increased in patients with coronary artery atherosclerosis. Cardiovasc Res 1994; 28: 1348-52.